Skip to main content
SpringerLink
Log in

Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children

  • Correspondence
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pusiol A, Cesaro S, Nocerino A, Picco G, Zanesco L, Bisogno G (2004) Successful treatment with the monoclonal antibody rituximab in two children with refractory autoimmune thrombocytopenia. Eur J Pediatr 163: 305–307

    Google Scholar 

  2. Russo G, Licciardello M, La Spina M (2004) Rituximab in children with idiopathic thrombocytopenic purpura: does it really work? Eur J Pediatr 163: 569

    Google Scholar 

  3. Stasi R, Provan D (2004) Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 79: 504–522

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Haematology and Oncology, Department of Paediatrics, University Hospital of Rijeka, Istarska 43, 51000 , Rijeka, Croatia

    Jelena Roganovic

Authors
  1. Jelena Roganovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jelena Roganovic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roganovic, J. Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children. Eur J Pediatr 164, 334 (2005). https://doi.org/10.1007/s00431-005-1631-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-005-1631-1

Keywords

Search

Navigation